Menopause symptom assessment
Structured evaluation of hot flashes, night sweats, sleep disruption, mood changes, brain fog, menstrual irregularity, vaginal dryness, dyspareunia, urinary symptoms, libido, joint pain, and muscle changes.
Evidence-based, physician-led menopause care for hormones, heart health, metabolism, bone strength, sexual health, and quality of life — integrated into VIFM's advanced primary care model.
Medicine that knows your whole story.

At Virginia Institute of Family Medicine, menopause care is approached as more than symptom control. Menopause is a major endocrine transition that may affect sleep, mood, metabolism, cholesterol, blood pressure, body composition, bone density, sexual and urinary health, and musculoskeletal function.
Our program provides evidence-based evaluation and treatment for perimenopause, menopause, and postmenopause. We help women understand which symptoms are likely hormone-related, which are indirectly worsened by menopause, and which require a broader medical evaluation.

Menopause is not just hot flashes. We assess the full spectrum of midlife symptoms and the underlying medical drivers that a hormone-only clinic may miss.
Physician-led, evidence-based, and prevention-focused. We integrate hormone care with cardiometabolic prevention, nutrition, strength preservation, mental health, and sexual health.
Structured evaluation of hot flashes, night sweats, sleep disruption, mood changes, brain fog, menstrual irregularity, vaginal dryness, dyspareunia, urinary symptoms, libido, joint pain, and muscle changes.
We prioritize regulated, FDA-approved estradiol and progesterone-based regimens with individualized risk assessment. We do not routinely prescribe compounded hormones or pellets.
Blood pressure, lipids (including ApoB and Lp(a) when appropriate), A1c and insulin resistance, ASCVD risk, adverse pregnancy history, early or surgical menopause, sleep apnea risk, and lifestyle.
Assessment of joint pain, frozen shoulder, tendinopathy, osteoarthritis, muscle loss, fall risk, vitamin D and nutrition, and DEXA eligibility — the emerging menopause musculoskeletal syndrome.
Care for vaginal dryness, painful intercourse, urinary urgency and recurrent UTIs from GSM, and distressing low libido — with judicious, evidence-based use of testosterone only where indicated.
Anxiety, insomnia, irritability, depression, ADHD worsening, and burnout in perimenopause — evaluated for both endocrine and non-endocrine drivers, not treated as low estrogen by default.
Our program is physician-led, evidence-based, and prevention-focused. We evaluate whether hormone therapy is appropriate — and we also assess the broader medical causes of symptoms commonly attributed to menopause, including thyroid disease, anemia, sleep apnea, cardiometabolic disease, autoimmune disease, medication effects, depression, anxiety, and nutritional deficiencies.
When hormone therapy is indicated, we prioritize FDA-approved menopausal hormone therapy with individualized risk assessment and shared decision-making — not a one-size-fits-all prescription.
Establish menopause stage, symptoms, risks, contraindications, and your goals. Full review of symptom inventory, uterus and bleeding history, screening status, BP, BMI, waist, ASCVD and metabolic risk, bone risk, mood, sleep, sexual health, medications, and supplements.
We separate menopause-mediated, menopause-associated, and unrelated causes. Discuss whether hormone therapy is appropriate, FDA-approved options, non-hormonal options, and your cardiometabolic, bone, muscle, nutrition, movement, sleep and stress plan.
Review vasomotor symptoms, sleep, mood, bleeding, BP, breast tenderness, headaches, side effects, adherence, and dose adjustment — with progress against your metabolic goals.
Reassess benefits, risks, symptoms, cardiometabolic markers, and bone health, and decide together whether treatment should continue, evolve, or step down.
A program built for workplaces, executive health, and professional teams — teachers, nurses, government employees, and corporate organizations investing in the long-term health of their women leaders and workforce.
